Peter W M Johnson (Peter Wm Johnson, Peter Johnson, Peter W Johnson)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Community Dwelling

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia (2024)
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia (2024)
Chunye Zhang, Ellen Stelloo, Sharon Barrans, Francesco Cucco, Dan Jiang, Maria-Myrsini Tzioni, Zi Chen, Yan Li, Joost F Swennenhuis, Jasmine Makker, Lívia Rásó-Barnett, Hongxiang Liu, Hesham El-Daly, Elizabeth Soilleux, Nimish Shah, Sateesh Kumar Nagumantry, Maw Kyaw, Mahesh Panatt Prahladan, Reuben M Tooze, David Robert Westhead, Harma Feitsma, Andrew J Davies, Catherine Burton, Peter W M Johnson, Ming-Qing Du
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential. Leukemia 38 (3) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances (2023)
John R Davies, Laura K Hilton, Aixiang Jiang, Sharon L Barrans, Catherine Burton, Peter W M Johnson, Andrew John Davies, Ming-Qing Du, Reuben M Tooze, Francesco Cucco, Matthew A Care, Ryan D Morin, Christian Steidl, Chulin Sha, David Robert Westhead, David W Scott
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood advances (2023)
Stefano Luminari, Alexander Fossa, Judith Trotman, Daniel Molin, Francesco d'Amore, Gunilla Enblad, Leanne Berkahn, Sally F Barrington, John Radford, Massimo Federico, Amy A Kirkwood, Peter W M Johnson
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter W M Johnson
Are we reaching the maximum cure rate for Hodgkin lymphoma? Hematological oncology (2023)
Jack G Fisher, Amber D P Doyle, Lara V Graham, Shreyanshi Sonar, Benjamin Sale, Isla Henderson, Luis Del Rio, Peter W M Johnson, Yosef Landesman, Mark S Cragg, Francesco Forconi, Christopher J Walker, Salim I Khakoo, Matthew D Blunt
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Leukemia (2023)
Andrew John Davies, Sharon Barrans, Louise Stanton, Josh Caddy, Sam Wilding, Geoff Saunders, Christoph Mamot, Urban Novak, Andrew McMillan, Paul Fields, Graham P Collins, Richard Stephens, Francesco Cucco, Chulin Sha, Moniek van Hoppe, Reuben M Tooze, John R Davies, Gareth O Griffiths, Anna Schuh, Catherine Burton, David Robert Westhead, Ming-Qing Du, Peter W M Johnson
Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter W M Johnson, Sriram Balasubramanian, Brendan Hodkinson, S Martin Shreeve, Steven Sun, Srimathi Srinivasan, Andrew J Steele, Jessica Vermeulen, Laurie H Sehn, Wyndham H Wilson
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL co-expressing BCL2 and MYC in the phase 3 PHOENIX trial. Blood advances (2023)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian L Link, Eric Mou, Kerry Joane Savage, Pier Luigi Luigi Zinzani, Matthew John Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Paul Skipp, Alistair Bailey, Katy J McCann, Oliver Wood, Robert C Walker, Robert Parker, Nicola Ternette, Tim Elliott, Timothy J Underwood, Peter W M Johnson, Paul J Skipp
Identification of neoantigens in oesophageal adenocarcinoma. Immunology (2022)
Peter W M Johnson
Smart salvage treatment for Hodgkin lymphoma. Blood 139 (25) (2022)
Findlay Bewicke-Copley, Koorosh Korfi, Shamza Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon L Barrans, Suzan Jl van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon A Rule, Nicola Crosbie, Andrew James Clear, Maria Calaminici, Hendrik Friedrich Peter Runge, Robert K Hills, David W Scott, Lisa M Rimsza, Geetha Menon, Chulin Sha, John Davies, Ai Nagano, Andrew John Davies, Daniel Painter, Alexandra G Smith, John G Gribben, Kikkeri N Naresh, David Robert Westhead, Jessica Okosun, Andrew J Steele, Daniel James Hodson, Sriram Balasubramanian, Peter W M Johnson, Jun Wang, Jude Fitzgibbon
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma. Blood advances (2022)
Matthew D Blunt, Sócrates Herrera Valencia, Jack G Fisher, Lara V Graham, Amber D P Doyle, Rebecca Fulton, Matthew J Carter, Marta E Polak, Peter W M Johnson, Mark S Cragg, Francesco Forconi, Salim I Khakoo
KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity. Journal of immunology (Baltimore, Md. : 1950) 209 (2) (2022)
Richard D Neal, Peter W M Johnson, Christina A Clarke, Stephanie A Hamilton, Nan Zhang, Harpal Kumar, Charles Swanton, Peter D Sasieni
Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial. Cancers 14 (19) (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian L Link, Eric Mou, Kerry Joane Savage, Pier Luigi Luigi Zinzani, Matthew John Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jemma Longley, Peter W M Johnson
Personalized medicine for Hodgkin lymphoma: Mitigating toxicity while preserving cure. Hematological oncology (2021)
James Heward, Lola Konali, Annalisa D'Avola, Karina Close, Alison Yeomans, Martin Philpott, James E Dunford, Tahrima Rahim, Ahad F Al Seraihi, Jun Wang, Koorosh Korfi, Shamzah Araf, Sameena Iqbal, Findlay Bewicke-Copley, Emil Kumar, Darko Barisic, Maria Calaminici, Andrew James Clear, John G Gribben, Peter W M Johnson, Richard Neve, Pedro Rodriguez Cutillas, Jessica Okosun, Udo Oppermann, Ari M Melnick, Graham Packham, Jude Fitzgibbon
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas. Blood 138 (5) (2021)
Allan Relecom, Massimo Federico, Joseph M Connors, Bertrand Coiffier, Irene Biasoli, Alden Alberto Moccia, Gilles Salles, Thomas McKee, Raymond Miralbell, Peter Borchmann, John Kuruvilla, Peter W M Johnson, Franco Cavalli, Martine Delavy, Pierre-Yves Dietrich, Antoine Flahault
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma. International journal of environmental research and public health 17 (5) (2020)
Timothy A Yap, Jane N Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Jean Marie Michot, John P Leonard, Vincent Ribrag, Michael T McCabe, Caretha L Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar, Peter W M Johnson
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)
Samantha Drennan, Giorgia Chiodin, Annalisa D'Avola, Ian Tracy, Peter W M Johnson, Livio Trentin, Andrew J Steele, Graham Packham, Freda K Stevenson, Francesco Forconi
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2018)
Sean H Lim, Peter W M Johnson
Optimizing therapy in advanced-stage Hodgkin lymphoma. Blood 131 (15) (2018)